+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line



Type beta transforming growth factor and epidermal growth factor suppress the plasminogen activator activity in a human glioblastoma cell line



Journal of Neuro-Oncology 6(3): 277-284



In the human glioblastoma cell line, T-MG1, plasminogen activator activity (PA-activity) was demonstrated by using the chromogenic substrate S-2251. Using monoclonal antibodies against human urokinase type PA (u-PA) and human tissue type PA (t-PA), only u-PA activity was found in T-MG1 cell extracts. The u-PA activity in T-MG1 cells was suppressed in a dose-dependent manner by B-TGF and EGF after 24 hours of exposure to these growth factors. Twenty units of B-TGF caused a decrease in PA-activity of 80%, while 10 ng/ml EGF gave a decrease in PA-activity of 60%. The suppressive effects of B-TGF and EGF were observed after 2 hours and 4 hours of incubation, respectively and sustained for at least 24 hours. The effects of B-TGF and EGF were not antienzymatic, but rather mediated through regulatory mechanisms. In view of the capacity of invasive growth of gliomas and the potential role of PA in invasive growth, the suppression of PA-activity in gliomas by B-TGF and EGF may be of importance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007976184

Download citation: RISBibTeXText

PMID: 3265720

DOI: 10.1007/bf00163713


Related references

The effects of type beta transforming growth factor on proliferation and epidermal growth factor receptor expression in a human glioblastoma cell line. Journal of Neuro-Oncology 6(3): 269-276, 1988

Transforming growth factor-beta 1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines. Apmis 96(9): 845-849, 1988

The effect of transforming growth factor beta tgf beta on the plasminogen activator pa activity of normal human osteoblast like cells and a human osteosarcoma cell line. Calcified Tissue International 48(Suppl.): A44, 1991

Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. Laboratory Investigation; a Journal of Technical Methods and Pathology 77(1): 63-70, 1997

Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro. Journal of Investigative Dermatology 95(5): 607-613, 1990

The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63. Journal of Bone and Mineral Research 7(12): 1363-1371, 1992

Transforming growth factor-β1 is a potent inducer of plasminogen activator inhibitor type-1 in human glioblastoma and carcinoma cell lines. Apmis 96(7-12): 845-849, 1988

Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta. Current Eye Research 17(1): 79-87, 1998

Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. Cancer Research 48(22): 6384-6389, 1988

Autocrine growth mechanism by transforming growth factor (TGF)-beta 1 and TGF-beta 1-receptor regulation by epidermal growth factor in a human endometrial cancer cell line IK-90. International Journal of Cancer 54(5): 862-867, 1993

Receptors for transforming growth factor type beta tgf beta platelet derived growth factor pdgf fibroblast growth factor fgf and epidermal growth factor egf are regulated by cell density. Proceedings of the American Association for Cancer Research Annual Meeting 30: 72, 1989

Regulation of plasminogen activator inhibitor -1 expression in a human trophoblast cell line by glucocorticoid and transforming growth factor -beta. Placenta 23(10): 727-734, 2002

Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET. Cancer Research 53(17): 4041-4047, 1993

Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor. Journal of Biological Chemistry 287(15): 12520-8, 2012

Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells. Experimental Nephrology 5(3): 233-238, 1997